October 27, 2015
Health care costs for dementia found greater than for any other disease
In the last five years of life, total health care spending for people with dementia was more than a quarter-million…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
October 27, 2015
GW Pharmaceuticals signs MOU to research Epudiolex with New South Wales (Australia)
GW Pharmaceuticals plc, has signed a Memorandum of Understanding (MOU) with the Government of New South Wales (NSW) in Australia to progress a research program for Epidiolex (cannabidiol or CBD) and cannabidivarin (CBDV) in children with severe, drug resistant childhood epilepsy.
October 27, 2015
Allergan Acquires Rights To Ironwood’s Constella
Allergan plc and Ironwood Pharmaceuticals, Inc. have announced that Allergan has acquired rights to Constella (linaclotide) in the European Union, Switzerland, Turkey and the Commonwealth of Independent States from Almirall, S.A. and has also reacquired rights to Linzess (linaclotide) in Mexico from Almirall.
October 26, 2015
Strensiq: First approved treatment for perinatal
Strensiq is the first treatment for perinatal, infantile and juvenile-onset hypophosphatasia (HPP) approved approved by FDA.
October 26, 2015
FDA approves Yondelis for metastatic liposarcoma
Food and Drug Administration (FDA) has approved YONDELIS (trabectedin) for the treatment of patients with unresectable (unable to be removed…
October 26, 2015
Anavex joins NASDAQ
Anavex Life Sciences Corp., has announced it would be trading its common stock on the NASDAQ, an American/Canadian stock exchange, one…
October 26, 2015
Medicine for treating pancreatic cancer approved in US
The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat…
October 26, 2015
Cosentyx in Europe for psoriatic arthritis and ankylosing spondylitis
Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Cosentyx(TM) (secukinumab)…
October 21, 2015
Allergan’s Gel Drops show reduction in dry eye symptoms
REFRESH OPTIVE Gel Drops, a new aqueous gel expertly designed for patients who need or desire a more viscous artificial tear option to relieve their Dry Eye symptoms.
October 21, 2015
Prevalence of Marijuana Use Among U.S. Adults Doubles Over Past Decade
The percentage of Americans who reported using marijuana in the past year more than doubled between 2001-2002 and 2012-2013, and the increase in marijuana use disorder during that time was nearly as large.